Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.59 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.56 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 3/20 | 0.54 |
| ▸ | CA2 | P00918 | 3/20 | 0.54 |
| ▸ | MME | P08473 | 7/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | ACE | P12821 | 4/20 | 0.51 |
| ▸ | CPA1 | P15085 | 1/20 | 0.51 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL680562 | 1.00 | SLC7A5 (0.59) | SLC7A5FOLH1NAALAD2CA1CA2 | |
| SCHEMBL5153319 | 1.00 | SLC7A5 (0.59) | SLC7A5FOLH1NAALAD2CA1CA2 | |
| SCHEMBL8651835 | 0.86 | SLC7A5 (0.56) | SLC7A5FOLH1NAALAD2CA1CA2 | |
| SCHEMBL29486918 | 0.85 | CA2 (0.54) | SLC7A5FOLH1NAALAD2CA2MME | |
| SCHEMBL5694618 | 0.85 | GNPAT (0.58) | SLC7A5FOLH1NAALAD2MMEL3MBTL1 | |
| SCHEMBL93439 | 0.85 | GNPAT (0.58) | SLC7A5FOLH1NAALAD2MMEL3MBTL1 | |
| SCHEMBL93440 | 0.85 | GNPAT (0.58) | SLC7A5FOLH1NAALAD2MMEL3MBTL1 | |
| SCHEMBL412958 | 0.85 | GNPAT (0.58) | SLC7A5FOLH1NAALAD2MMEL3MBTL1 | |
| SCHEMBL13464491 | 0.84 | SLC7A5 (0.49) | SLC7A5FOLH1NAALAD2CA1CA2 | |
| SCHEMBL2772723 | 0.84 | TDP1 (0.54) | FOLH1MMEKMT2AL3MBTL1ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240216524-A1 | Chemoselective Rapid Azo-Coupling Reaction for Bioconjugation | TRUSTEES BOSTON COLLEGE (US) | 2024-07-04 | — | — | US | claimed |
| EP-4035698-A1 | WOUND DRESSING AND METHOD FOR PREPARING THE SAME | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2022-08-03 | — | — | EP | claimed |
| US-20210220298-A1 | METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING METABOLIC SYNDROME INDUCED BY ANTIPSYCHOTIC TREATMENT AND RELATED DISEASES AND CONDITIONS | TUFTS MEDICAL CENTER, INC. | 2021-07-22 | — | — | US | claimed |
| CN-112516057-A | Composite biological scar-removing factor nutritional scar-removing whitening cream and preparation method thereof | 郑楠 | 2021-03-19 | — | — | CN | claimed |
| US-20180360984-A1 | Chemoselective Rapid Azo-Coupling Reaction for Bioconjugation | TRUSTEES OF BOSTON COLLEGE | 2018-12-20 | — | — | US | claimed |
| CN-102224238-B | Non-natural amino acid replication-dependent microorganisms and vaccines | AMBRX INC | 2015-06-10 | — | — | CN | claimed |
| US-8969288-B2 | Amide based glucagon and superfamily peptide prodrugs | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2015-03-03 | — | — | US | claimed |
| CN-103864892-A | Peptide tyrosinase inhibitors and uses thereof | UNIV LELAND STANFORD JUNIOR | 2014-06-18 | — | — | CN | claimed |
| CN-102203257-B | 3-amino tyrosine genetic incorporation of reductases | SCRIPPS RESEARCH INST | 2014-01-08 | — | — | CN | claimed |
| CN-102369210-A | Antibacterial peptide | AMP THERAPEUTICS GMBH & CO KG | 2012-03-07 | — | — | CN | claimed |
| CN-101970005-A | Breaking immunological tolerance with a genetically encoded unnatural amino acid | SCRIPPS RESEARCH INST | 2011-02-09 | — | — | CN | claimed |
| WO-2010071807-A1 | AMIDE BASED GLUCAGON SUPERFAMILY PEPTIDE PRODRUGS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2010-06-24 | — | — | WO | claimed |
| US-20030165983-A1 | Proteomic determination of protein nitrotyrosine modifications using mass spectrometry | REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE | 2003-09-04 | — | — | US | claimed |
| WO-2001084160-A2 | PROTEOMIC DETERMINATION OF PROTEIN NITROTYROSINE MODIFICATIONS USING MASS SPECTROMETRY | MITOKOR (US) | 2001-11-08 | — | — | WO | claimed |
| EP-0785921-B1 | PROCESS FOR PRODUCING SODIUM 1-THYROXINE COMPRISING THE OXIDATIVE COUPLING OF A DIIDO-1-TYROSINE CATALYSED BY A MANGANESE SALT IN THE PRESENCE OF AN AMINE | KNOLL AG (DE) | 2000-04-26 | — | — | EP | claimed |
| US-5384116-A | Synthetic melanin as a sunscreen and tanning agent | YALE UNIVERSITY (US) | 1995-01-24 | — | — | US | claimed |
| EP-0089365-A4 | New Dye or Fluorescent polymers and their use as labels in immunoassay systems. | HENRY ROBERT P | 1985-08-21 | — | — | EP | claimed |
| US-4452886-A | Novel photon absorbing or emitting polymers and their use as reagents in immunoassay systems | PHOTEST DIAGNOSTICS, INC. A CORPORATION OF DE | 1984-06-05 | — | — | US | claimed |
| EP-0089365-A1 | New Dye or Fluorescent polymers and their use as labels in immunoassay systems. | PHOTEST DIAGNOSTICS, INC. (US) | 1983-09-28 | — | — | EP | claimed |
| WO-1983001064-A1 | NOVEL PHOTON ABSORBING OR EMITTING POLYMERS AND THEIR USE AS REAGENTS IN IMMUNOASSAY SYSTEMS | HENRY, ROBERT, P. | 1983-03-31 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210220298-A1 | METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING METABOLIC SYNDROME INDUCED BY ANTIPSYCHOTIC TREATMENT AND RELATED DISEASES AND CONDITIONS | GPR119, PC, NLN | SLC7A5 4169/4885FOLH1 3730/4885NAALAD2 2857/4885 |
| US-20240216524-A1 | Chemoselective Rapid Azo-Coupling Reaction for Bioconjugation | PAICS, DNPEP, ABCG2 | SLC7A5 127/4885FOLH1 712/4885NAALAD2 18/4885 |
| US-20180360984-A1 | Chemoselective Rapid Azo-Coupling Reaction for Bioconjugation | PAICS, DNPEP, ABCG2 | SLC7A5 127/4885FOLH1 712/4885NAALAD2 18/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.